OMCL 250117 50.00C (OMCL250117C50000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

OMCL250117C50000

Watchlist

0.12
-0.14-53.85%

15min DelayClose Jan 10 16:00 ET

0.12High0.12Low

Intraday

5D
Daily

News

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BusinesswireJan 8 16:01 ET
HOLX Stock Gains Following the Acquisition of Gynesonics
Zacks Jan 7 07:05 ET
Omnicell Is Maintained at Neutral by B of A Securities
Dow JonesJan 6 13:09 ET · Ratings
Omnicell Price Target Cut to $46.00/Share From $54.00 by B of A Securities
Dow JonesJan 6 13:09 ET · Ratings
Omnicell Analyst Ratings
BenzingaJan 6 12:58 ET · Ratings
BofA Securities Maintains Omnicell(OMCL.US) With Hold Rating, Cuts Target Price to $46
Moomoo NewsJan 6 09:33 ET · Ratings

Comments

Moomoo AI

Feb 23, 2024 05:55

Omnicell stock is undervalued, presenting a buying opportunity. The company's future outlook is optimistic with robust cash flows expected to increase share value. However, consider other factors like financial health before investing.

Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?

Moomoo AI

Feb 5, 2024 08:15

The company's debt situation and EBIT loss of US$31m over the last twelve months raise concerns about its financial health. The balance sheet is considered far from match-fit and the stock is deemed very risky.

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Moomoo AI

Dec 25, 2023 05:09

Omnicell's low P/S ratio suggests limited growth. Lackluster future revenue forecasts damages its value. Investors await improved performance as current weak outlook pressures stock price.

Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Is Matching Sentiment Around Its Revenues

Moomoo AI

Dec 6, 2023 05:40

Given the falling EPS and poor performance over the last three years, future earnings performance is being considered critical for shareholders. Potential investors are cautioned to ensure they are investing in a high-quality business amid challenges.

Shareholders in Omnicell (NASDAQ:OMCL) Have Lost 70%, as Stock Drops 3.2% This Past Week